Enzo Biochem Inc financial data

Symbol
ENZ on NYSE
Industry
Services-Medical Laboratories
Location
60 Executive Blvd, Farmingdale, NY
State of incorporation
NY
Fiscal year end
July 31
Latest financial report
10-K - Q2 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 313 % +105%
Quick Ratio 29.4 % -25.6%
Debt-to-equity 42.4 % -58.9%
Return On Equity -38.6 % -183%
Return On Assets -27.1 % -219%
Operating Margin -38.8 % +51.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.2M shares +3.48%
Common Stock, Shares, Outstanding 52.2M shares +4.49%
Entity Public Float 57.5M USD +1.97%
Common Stock, Value, Issued 521K USD +4.41%
Weighted Average Number of Shares Outstanding, Basic 50.9K shares +3.54%
Weighted Average Number of Shares Outstanding, Diluted 50.9K shares +3.54%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 31.9M USD +2.72%
Cost of Revenue 17.3M USD -3.31%
Research and Development Expense 2.64M USD -32.3%
Costs and Expenses 29.4M USD -4.47%
Operating Income (Loss) -12.4M USD +50%
Nonoperating Income (Expense) -88K USD -119%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.82M USD +60.8%
Net Income (Loss) Attributable to Parent -26.1M USD -229%
Earnings Per Share, Basic -0.51 USD/shares -224%
Earnings Per Share, Diluted -0.51 USD/shares -224%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.4M USD -36.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.99M USD -17.1%
Inventory, Net 6.83M USD -13.9%
Assets, Current 70M USD -28.9%
Property, Plant and Equipment, Net 12.4M USD -5.49%
Operating Lease, Right-of-Use Asset 2.84M USD -21.8%
Intangible Assets, Net (Excluding Goodwill) 29K USD -90.8%
Goodwill 7.45M USD 0%
Other Assets, Noncurrent 530K USD -90.8%
Assets 85.8M USD -29.6%
Employee-related Liabilities, Current 6.45M USD +50.8%
Accrued Liabilities, Current 5.71M USD -51.3%
Liabilities, Current 24.8M USD -38%
Operating Lease, Liability, Noncurrent 2.4M USD -24%
Other Liabilities, Noncurrent 18K USD -81.3%
Liabilities 29.7M USD -31.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.89M USD +0.37%
Retained Earnings (Accumulated Deficit) -294M USD -9.72%
Stockholders' Equity Attributable to Parent 56.1M USD -28.5%
Liabilities and Equity 85.8M USD -29.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.4M USD -53.8%
Net Cash Provided by (Used in) Financing Activities -518K USD -445%
Net Cash Provided by (Used in) Investing Activities -254K USD +61%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 52.2M shares +4.49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.2M USD -49.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.4M USD -37.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 53K USD -5.36%
Deferred Tax Assets, Valuation Allowance 29.7M USD +11.2%
Deferred Tax Assets, Gross 31.1M USD +3.8%
Operating Lease, Liability 3.24M USD -21.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -26.1M USD -237%
Lessee, Operating Lease, Liability, to be Paid 3.55M USD -23.2%
Property, Plant and Equipment, Gross 27.1M USD -4.26%
Operating Lease, Liability, Current 841K USD -14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 886K USD -1.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 978K USD -15.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 309K USD -36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 881K USD -0.56%
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 808K USD -8.29%
Additional Paid in Capital 348M USD +1.07%
Amortization of Intangible Assets 22K USD -75.6%
Depreciation, Depletion and Amortization 270K USD -65.4%
Deferred Tax Assets, Net of Valuation Allowance 29.7M USD +11.2%
Share-based Payment Arrangement, Expense 1.72M USD +10.5%
Interest Expense -1.38M USD -2117%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%